1. Home
  2. SCLX vs INVE Comparison

SCLX vs INVE Comparison

Compare SCLX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.79

Market Cap

55.1M

Sector

Health Care

ML Signal

HOLD

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$2.73

Market Cap

65.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
INVE
Founded
2011
1990
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
55.1M
65.1M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
SCLX
INVE
Price
$6.79
$2.73
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
119.0K
244.7K
Earning Date
04-10-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$60,219,000.00
Revenue This Year
$122.52
$22.10
Revenue Next Year
$186.30
$20.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.21
52 Week Low
$4.20
$2.43
52 Week High
$34.27
$5.30

Technical Indicators

Market Signals
Indicator
SCLX
INVE
Relative Strength Index (RSI) 39.46 32.13
Support Level $5.72 $2.43
Resistance Level $7.77 $3.83
Average True Range (ATR) 0.79 0.13
MACD -0.26 0.02
Stochastic Oscillator 0.27 3.64

Price Performance

Historical Comparison
SCLX
INVE

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

Share on Social Networks: